![](https://investorshub.advfn.com/uicon/477123.png?cb=1533675489)
Thursday, August 10, 2017 2:16:34 PM
This will be sold at $2.50 - $3. I wish more but realistically not possible
they will get 2 more partnered Generics XR approved probably by end of year - possibly 3 with Ranexa.
They should bring in at least $10 million each possibly $15 million each.
So even if we underestimate their worth:
Seroquel XR $20 Million
Pristiq $10 million
Lamictal $7 million
Ranexa $10 million
Focalin $4 million
Yea - over $50 million in royalty payments within a year or two and they are going to sell themselves off for 2x earnings.
BULLSHIT!!!
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM